SABBY MANAGEMENT, LLC's Net Worth

$3.14 Million

Estimate Recalculated Aug 12, 2024 10:16AM EST

Who is SABBY MANAGEMENT, LLC?

SABBY MANAGEMENT, LLC has an estimated net worth of $3.14 Million. This is based on reported shares across multiple companies, which include ReShape Lifesciences Inc., Rosetta Genomics Ltd., NUPATHE INC., and Celsus Therapeutics Plc..

SEC CIK

SABBY MANAGEMENT, LLC's CIK is 0001535610

Past Insider Trading and Trends

2018 was SABBY MANAGEMENT, LLC's most active year for acquiring shares with 28 total transactions. SABBY MANAGEMENT, LLC's most active month to acquire stocks was the month of February. 2012 was SABBY MANAGEMENT, LLC's most active year for disposing of shares, totalling 1 transactions. SABBY MANAGEMENT, LLC's most active month to dispose stocks was the month of January. 2014 saw SABBY MANAGEMENT, LLC paying a total of $856,710.07 for 146,589 shares, this is the most they've acquired in one year. In 2019 SABBY MANAGEMENT, LLC cashed out on 1,192,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ReShape Lifesciences Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-99.96%
-1.18M
$0.27
$2,815.26
507
Jan 31 - Feb 1
Form 4
+5.37%
60.2K
$0.28
$16,830.38
1.18M
Jan 29 - Jan 30
Form 4
+1.98%
21.79K
$0.27
$5,815.61
1.12M
Jan 24 - Jan 25
Form 4
+0.53%
5.77K
$0.28
$1,609.29
1.1M
Jan 22
Form 4
+2.28%
24.39K
$0.28
$6,801.31
1.09M
Jan 17 - Jan 18
Form 3
—
0
—
—
0
Form 4
+22.20%
194.42K
$0.24
$46,612.53
1.07M
Jan 15 - Jan 16
No matching records found

Rosetta Genomics Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
+0.76%
7.08K
$0.35
$2,479.75
941.69K
Apr 26
Form 4
+7.39%
64.3K
$0.43
$27,728.24
934.61K
Mar 16
Form 4
+15.96%
119.76K
$0.42
$50,390.85
870.31K
Mar 14 - Mar 15
Form 4
+30.59%
175.83K
$0.42
$73,344.93
750.55K
Mar 12 - Mar 13
Form 3
—
0
—
—
0
No matching records found

NUPATHE INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 23 - Nov 8
Form 3
—
0
—
—
0
No matching records found

Celsus Therapeutics Plc. (AKTX) Snapshot price: $2.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
+2.65%
20.1K
$5.03
$101,130.00
778.03K
Apr 14 - Apr 15
Form 4
+0.34%
2.58K
$5.35
$13,788.25
757.93K
Apr 9 - Apr 11
Form 4
+9.96%
68.4K
$5.59
$382,520.00
755.36K
Apr 4 - Apr 8
Form 4
+1.42%
28.21K
$6.37
$175,534.12
2.02M
Mar 17 - Apr 2
Form 4
+2.52%
16.2K
$6.66
$107,946.70
658.74K
Mar 25 - Mar 27
Form 4
+1.76%
11.1K
$6.83
$75,791.00
642.54K
Mar 20 - Mar 24
Form 3
—
0
—
—
0
No matching records found

Volcon, Inc. (VLCN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.37%
15.13K
$1.65
$24,928.80
654.13K
Aug 8 - Aug 9
Form 4
+7.85%
46.53K
$1.91
$81,755.68
638.99K
Aug 6 - Aug 7
No matching records found